Find clinical trials for Pancreatic Cancer in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Seattle, WA, USA:
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...
Phase 3
Seattle, Washington, United States and 33 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Seattle, Washington, United States and 135 other locations
The purpose of this study is to evaluate the safety and efficacy of samuraciclib in patients with localized pancreatic cancer....
Phase 1
Seattle, Washington, United States
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Seattle, Washington, United States and 11 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Seattle, Washington, United States and 108 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...
Phase 1
Seattle, Washington, United States and 76 other locations
The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combinatio...
Phase 3
Seattle, Washington, United States and 12 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Tacoma, Washington, United States and 91 other locations
evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...
Phase 2
Seattle, Washington, United States and 21 other locations
. Zolbetuximab attaches to a protein called CLDN18.2 found at high levels on the surface of the cancer tumor. This switches on the ...
Phase 1
Seattle, Washington, United States
Clinical trials
Research sites
Resources
Legal